Emily English, CEO of Gemstone Biotherapeutics sits down with BioTalk host Rich Bendis to discuss company’s history, the path to her role, and the evolution of their technology.
Emily English, CEO of Gemstone Biotherapeutics sits down with BioTalk host Rich Bendis to discuss company’s history, the path to her role, and the evolution of their technology. Emily P. English, Ph.D., is the Chief Executive Officer of Gemstone Biotherapeutics, LLC. Dr. English is a proven innovator and manager with a passion for transitioning early-stage technologies to operational capabilities and commercial products. In her current role, she is guiding the commercialization of Gemstone’s innovative biomaterials technology, with a goal of bringing solutions for scar-free skin regeneration to market. Prior to joining Gemstone, Dr. English spent eight years at the Johns Hopkins University Applied Physics Laboratory, where she was the Global Communications Program Manager and led a team of 35 scientists and engineers. She holds a Bachelor’s degree, Magna cum laude, in chemistry from the University of Maryland, College Park, and a Ph.D. in chemistry from the University of Wisconsin, Madison. Outside of work, Dr. English enjoys spending time with her family, and she is an avid curler.
Listen now on iTunes , Google Play , and TuneIn.